Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

WYE-130600 may cause skin thickening and irritation.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

A new compound was effective for imaging prostate cancer in rats.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

A group has developed therapies that show promise for treating cancer and various other conditions.